Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Eyepoint Pharmaceuticals Inc
(NQ:
EYPT
)
8.700
-0.050 (-0.57%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Eyepoint Pharmaceuticals Inc
< Previous
1
2
3
4
5
Next >
Super Micro Computer, Garrett Motion, Rackspace Technology And Other Big Stocks Moving Lower On Monday
April 24, 2023
U.S. stocks traded mixed, with the Nasdaq Composite dropping around 50 points on Monday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Nasdaq Edges Higher; Procter & Gamble Posts Upbeat Earnings
April 21, 2023
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite edging higher on Friday. The Dow traded down 0.06% to 33,765.47 while the NASDAQ rose 0.02% to 12,062.18. The S&P 500, also...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
April 21, 2023
Via
Benzinga
Gold Down Over 1%; US Composite PMI Rises In April
April 21, 2023
U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 70 points on Friday. The Dow traded down 0.20% to 33,718.74 while the NASDAQ fell 0.33% to 12,019.40. The S&P 500,...
Via
Benzinga
Earnings Preview: EyePoint Pharmaceuticals
March 01, 2023
Via
Benzinga
EyePoint Pharma Posts 12-Month Safety, Efficacy Data From Early-Stage Wet AMD Trial
July 15, 2022
Via
Benzinga
Chardan Forecasts Over 160% Upside On This Eye Disease-Focused Stock
July 07, 2022
Via
Benzinga
EyePoint, Expands Pact With Betta Pharma For EYP-1901 In China, Posts Deeper Q1 Loss
May 04, 2022
Via
Benzinga
Why SAP Shares Are Trading Higher By Around 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session
April 21, 2023
Gainers Mangoceuticals, Inc. (NASDAQ: MGRX) shares jumped 207% to $2.84. The company announced Thursday, that it's featured on Webull Corporate Communications Service Platform.
Via
Benzinga
US Stocks Mostly Lower; Nasdaq Down 50 Points
April 21, 2023
U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping around 50 points on Friday. Following the market opening Friday, the Dow traded down 0.03% to 33,777.38 while the NASDAQ...
Via
Benzinga
Finance Executives Look For Ways To Diversify Cash Strategies After Silicon Valley Bank's Fallout
March 16, 2023
Financial officers at companies with money held at Silicon Valley Bank (NASDAQ: SIVB) are re-evaluating their cash-management strategies.
Via
Benzinga
EyePoint Pharma Posts Deeper Losses For Q4, Expects Cash Runway Into 2024
March 02, 2023
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) has reported Q4 revenues of $10.5 million, down 8.8% Y/Y, almost in line with the consensus of $10.40 million.
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
February 03, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
January 12, 2023
Via
Benzinga
AiViva Reports That Their Promising New Treatment For Wet AMD Is Soon To Be Ready For Clinical Trials
November 14, 2022
Visit https://www.startengine.com/aiviva to invest in AiViva’s StartEngine Campaign.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
November 30, 2022
During Wednesday's session, 107 stocks hit new 52-week lows.
Via
Benzinga
EyePoint Pharmaceuticals: Q3 Earnings Insights
November 02, 2022
EyePoint Pharmaceuticals (NASDAQ:EYPT) reported its Q3 earnings results on Wednesday, November 2, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Meet The Company Bringing New Treatments For Serious Eye Issues To Market
October 05, 2022
Sign up for this week’s All Access giveaway here!
Via
Benzinga
Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial
August 03, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Recap: EyePoint Pharmaceuticals Q2 Earnings
August 03, 2022
EyePoint Pharmaceuticals (NASDAQ:EYPT) reported its Q2 earnings results on Wednesday, August 3, 2022 at 07:30 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
October 05, 2022
Wednesday saw 127 companies set new 52-week lows.
Via
Benzinga
Earnings Preview For EyePoint Pharmaceuticals
August 02, 2022
EyePoint Pharmaceuticals (NASDAQ:EYPT) is set to give its latest quarterly earnings report on Wednesday, 2022-08-03. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
Recap of Monday's Biotech Catalysts - End of the Day Summary
July 18, 2022
Abbvie (NYSE: ABBV) has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for atogepant for the prophylaxis of migraine in adult patients who have at least...
Via
Benzinga
Why Bank Stocks Traded Sharply Higher; Here's 65 Biggest Movers From Friday
July 18, 2022
Gainers United Maritime Corporation (NASDAQ: USEA) shares climbed 175.9% to close at $6.07 on Friday. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
July 15, 2022
Via
Benzinga
EyePoint Announces Positive Safety and Efficacy Data From Initial-Stage Wet AMD Study
July 15, 2022
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) announced 12-month data readout from the Phase 1 DAVIO clinical trial evaluating EYP-1901, targeting wet age-related macular degeneration (wet AMD) as a...
Via
Benzinga
7 Wildly Oversold Nasdaq Stocks to Buy Now
July 12, 2022
For speculators that are seeking the next big upside opportunity, you may consider these oversold Nasdaq stocks to buy now.
Via
InvestorPlace
Recap of Tuesday's Biotech Catalysts - End of the Day Summary
June 21, 2022
Ionis (NASDAQ: IONS) announced that Eplontersen met co-primary and secondary endpoints in interim analysis of the Phase 3 NEURO-TTRansform study for hereditary transthyretin-mediated amyloid...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 7, 2022
July 07, 2022
Upgrades
Via
Benzinga
Recap: EyePoint Pharmaceuticals Q1 Earnings
May 04, 2022
EyePoint Pharmaceuticals (NASDAQ:EYPT) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.